Concepedia

Caroline Kerridge

CK

4

Publications

338

Citations

4

H-Index

2014

Active since

Affiliations

Eli Lilly (United Kingdom)(Current)

Institute of Evolutionary Physiology and Biochemistry

University of Leeds

Caroline Kerridge is an author at Eli Lilly (United Kingdom) specializing in neurodegenerative diseases, medicine, and cellular biochemistry.

Top concepts

MedicineNeurodegenerative DiseasesCell BiologyCell SignalingSystems BiologyAlzheimer's DiseaseMolecular SignalingSignal TransductionCellular BiochemistryMolecular Neuroscience

Publications per year

2014–2019

4

Publications

4

Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau

Samuel J. Jackson, Caroline Kerridge, Jane Cooper et al. · Journal of Neuroscience · 2016 · 158 citations · Full text

Transgenic Mouse Models, Genetics, Molecular Genetics +17

The Aβ‐clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain

Caroline Kerridge, Nikolai D. Belyaev, Natalia N. Nalivaeva et al. · Journal of Neurochemistry · 2014 · 72 citations

Molecular Regulation, Molecular Biology, Amyloid Precursor Protein +18

Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network

Anan Yu, Susan G. Fox, Annalisa Cavallini et al. · Journal of Biological Chemistry · 2019 · 59 citations · Full text

Hypoxia Affects Neprilysin Expression Through Caspase Activation and an APP Intracellular Domain-dependent Mechanism

Caroline Kerridge, D. I. Kozlova, Natalia N. Nalivaeva et al. · Frontiers in Neuroscience · 2015 · 49 citations · Full text

Cell Death, Neurochemical Biomarkers, Amyloid Precursor Protein +30

Rows per page

1–4 of 4